| Total | Non-frailty | Frailty | P |
Duration (years) | 14.1 (19.8 - 9) | 12 (9 - 19) | 13.5 (10 - 20) | 0.351 |
BMI (kg/m2) | 23.8 (21.4 - 26.4) | 23.9 (21.7 - 26.2) | 23.1 (20.8 - 26.7) | 0.576 |
MMSE (points) | 28 (25 - 29) | 28 (26 - 30) | 26 (23 - 30) | P < 0.05 |
Medications (n) | 6 (4 - 8) | 5 (3 - 7.3) | 8 (6 - 9) | P < 0.05 |
Insulin (%) | 44 (24.7) | 33 (22.9) | 12 (31.6) | 0.292 |
Peripheral neuropathy (%) | 92 (51.7) | 67 (47.9) | 25 (65.8) | 0.0667 |
Retinopathy (%) | 57 (32) | 42 (29.3) | 16 (42.1) | 0.17 |
Nephropathy (%) | 109 (61.2) | 82 (57.6) | 27 (71.1) | 0.191 |
Hypertension (%) | 111 (62.4) | 84 (60) | 27 (71.1) | 0.259 |
Dyslipidemia (%) | 137 (77.0) | 114 (81.4) | 23 (60.5) | P < 0.05 |
CAD (%) | 35 (19.7) | 26 (18.6) | 9 (23.7) | 0.494 |
CVD (%) | 15 (8.43) | 10 (7.1) | 5 (13.2) | 0.319 |
PAD (%) | 23 (12.9) | 15 (10.7) | 8 (21.1) | 0.105 |